¿À¸Þ°¡-3 Áö¹æ»ê ÇÔÀ¯ º¹ºÐÀÚÁ¾ÀÚÀ¯¿¡ ÀÇÇÑ °íÁö¹æ½ÄÀÌ À¯µµ °íÁöÇ÷Áõ ¸¶¿ì½ºÀÇ Ç÷Áß Áß¼ºÁö¹æ ¹× ÄÝ·¹½ºÅ×·Ñ °¨¼Ò È¿°ú
Reduction of Plasma Triglycerides and Cholesterol in High Fat Diet-Induced Hyper-Lipidemic Mice by n-3 Fatty Acid from Bokbunja (Rubus coreanus Miquel) Seed Oil

Journal of the Korean Society of Food Science and Nutrition 2015³â 44±Ç 7È£ p.961 ~ p.969

ÀüÇý¸°(Jeon Hye-Lin) - ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ
¿À¼öÁø(Oh Su-Jin) - (ÁÖ)Á¦ÀÌÅ©¸°º£¸®³Ê¸®
³²Çö¼ö(Nam Hyun-Soo) - (ÁÖ)Á¦ÀÌÅ©¸°º£¸®³Ê¸®
¼ÛÀ±¼®(Song Yoon-Seok) - ÀüºÏ»ý¹°»ê¾÷ÁøÈï¿ø
ÃÖ°æö(Choi Kyung-Chul) - ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ

Abstract

To investigate the effect of n-3 fatty acid from Bokbunja (Rubus coreanus Miq.) seed oil (BSO), we examined improvement of plasma triglycerides and cholesterol in vivo. Five-week-old ICR mice were divided into five groups of six mice each; Control, high fat diet (HFD) control (negative control), salmon oil control (positive control, HFD+commercial n-3 fatty acid), and BSO¡¡experimental groups (HFD+1 g/60 kg BW/d, HFD+2 g/60 kg BW/d). After 4 weeks of BSO treatment, we measured serum triglyceride and cholesterol levels. The levels of low-density lipoprotein/very-low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, and total cholesterol were significantly (P<0.05) reduced in the group fed BSO at 2 g/60 kg BW/d compared to the negative control. Levels of triglycerides, which are similar to cholesterol, were also significantly (P<0.05) reduced in the same group. To investigate further, we tested blood coagulation parameters. Prothrombin time (PT) and activated partial thromboplastin time (aPTT) were not significantly different among the five groups according to BSO. However, the 2 g/60 kg BW/d BSO group treated with PT and aPTT showed a tendency to live longer than the negative control. Taken together, BSO might improve blood homeostasis mediated via hypo-lipidemic and anti-coagulation activities.

Å°¿öµå

Bokbunja seed oil, Rubus coreanus, hyper-lipidemia, blood flow improvement, omega-3
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
BSO might improve blood homeostasis mediated via hypo-lipidemic and anti-coagulation activities.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå